UBS Lux Equity Fund Biotech USD vs Invesco FTSE Emerging Markets High Dividend Low Volatility

UBS Lux Equity Fund Biotech USD vs Invesco FTSE Emerging Markets High Dividend Low Volatility

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. Invesco FTSE Emerging Markets High Dividend Low Volatility

  • Security

    Invesco FTSE Emerging Markets High Dividend Low Volatility UCITS ETF Dist

  • Fee

    0.49%

  • ISIN

    IE00BYYXBF44

  • Holdings

    6

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Invesco FTSE Emerging Markets High Dividend Low Volatility, we have 7 holdings where Vedanta is the largest holding (3.17), followed by ČEZ (2.44) and CEMIG (1.91).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Invesco FTSE Emerging Markets High Dividend Low Volatility.

UBS Lux Equity Fund Biotech USD Invesco FTSE Emerging Markets High Dividend Low Volatility
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Vedanta Ltd
India
3.17 %
2. Moderna Inc
9.21 %
2. ČEZ AS
Czech Republic
2.44 %
3. Gilead Sciences Inc
USA
4.66 %
3. Companhia Energética de Minas Gerais ADR
Brazil
1.91 %
4. BioNTech SE
4.13 %
4. China Shenhua Energy Co Ltd Class H
China
1.9 %
5. Karuna Therapeutics Inc
3.75 %
5. China Petroleum & Chemical Corp Class H
China
1.73 %
- 6. Bancolombia SA ADR
Colombia
1.52 %

The list of fund holdings was last updated on September 10, 2025.